XNYS · CRL
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
$286.64
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
CRL
Charles River Laboratories International, Inc.
Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
STRONG

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

82/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 17 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for CRL until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is CRL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CRL catalysts
About Charles River Laboratories International, Inc.
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Founded
1947
Listed
2000
Employees
20K
Country
US

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$286.64
Last session
Day high
$286.64
Last session
Day low
$286.64
Last session
Previous close
$286.64
52W high
$286.64
0.00% from high
52W low
$145.57
100% of range
Market cap
$13.4B
P/E
156.63×
EPS
$1.83
Beta
0.65
Shares out
47.7M
Avg volume
913.4K
VWAP
$286.64
Last session
Price history computed in-house
1W
+1.65%
1M
+27.76%
3M
+83.71%
1Y
+82.60%
YTD
+43.69%
SMA 50 $225.90 · above
SMA 200 $191.84 · above
52W position 100%

CRL overview

Veridion Score
Not reported
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CRL.Congress trackerSearch the public STOCK Act disclosure ledger.Thematic map · TechBio & AI Drug DiscoveryMethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CRL Form 4 filings
Public disclosures

Congress activity in CRL

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CRL in the cached public ledger.

Federal contracts

CRL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRL in this window.
Lobbying spend

CRL lobbying filings, year to date.

Registered lobbying filings matched to Charles River Laboratories International, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRL in this window.
Loading news for CRL
Analyst ratings
Sovereign unlock shows live analyst consensus for CRL.
Options
Sovereign unlock shows live options positioning for CRL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.